Article
E.U. paediatric MOG consortium consensus: Part 4 - Outcome of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders.
European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society - 1 Nov 2020
Bruijstens Arlette L, Breu Markus, Wendel Eva-Maria, Wassmer Evangeline, Lim Ming, Neuteboom Rinze F, Wickström Ronny, Baumann M, Bartels F, Finke C, Adamsbaum C, Hacohen Y, Rostasy K
Abstract excerpt
There is increasing knowledge on the role of antibodies against myelin oligodendrocyte glycoprotein (MOG-abs) in acquired demyelinating syndromes and autoimmune encephalitis in children. Better understanding and prediction of outcome is essential to guide treatment protocol decisions. Therefore, this part of the Paediatric European Collaborative Consensus provides an oversight of existing knowledge of clinical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
